Search by Medical Condition
A B C D E F G H I J K L M N O P Q R S T U V W X Y ZClinical Trials for Barrett Esophagus
- Oral Bevacizumab-800CW and Cetuximab-800CW Administration to Detect Early Esophageal Adenocarcinomas
- Itraconazole to Prevent Recurrent Barrett's Esophagus
- GCC Agonist Signal in the Small Intestine
- Obeticholic Acid for Prevention in Barrett's Esophagus
- PPI Therapy Impact on GERD After Sleeve Gastrectomy
- On-demand PPI Therapy is Effective on Controlling Symptoms in Patients With Barrett's Esophagus.
- Argon Plasma Coagulation for Barrett's Esophagus
- Detection of Early Esophageal Cancer by NIR-FME.
- Phase 1B Study of KSP/QRH Dimer for Detection of Neoplasia in the Esophagus
- Study of Multiplexed Heptapeptides for Detection of Neoplasia in the Esophagus
- Molecular Fluorescence Endoscopy of (Pre)Malignant Esophageal Lesions
- The Impact of Adjuvant Liquid Alginate on Endoscopic Ablation Therapy of Complicated Barrett's Esophagus
- Expression and Function of the Renin-Angiotensin System in the Esophagus
- TREAT-BE Study (Treatment With Resection and Endoscopic Ablation Techniques for Barrett's Esophagus)
- "Acetic Acid Chromoendoscopy in Barrett's Esophagus Surveillance
- YF476 in Barrett's Esophagus
- Aspirin in Preventing Disease Recurrence in Patients With Barrett Esophagus After Successful Elimination by Radiofrequency Ablation
- Trial to Assess the Effects of an Antimicrobial Mouthwash on the Esophageal Microbiome
- "Using Dilute Vinegar to Find Changes in Cells During Endoscopy for Patients With Barrett's Oesophagus" (The ABBA Study)
- Effect of Dexlansoprazole 60 mg QD and 60 mg BID on Recurrence of Intestinal Metaplasia in Subjects Who Have Achieved Complete Eradication of Barrett's Esophagus With Radiofrequency Ablation
- The Changes of Ryodoraku and HRV After PPI Treatment in GERD Patients
- Tamoxifen to Treat Barrett's Metaplasia
- Accuracy, Yield and Clinical Impact of a Low-Cost HRME in the Early Diagnosis of Esophageal Adenocarcinoma
- Barretts oEsophageal Resection With Steroid Therapy Trial
- Effect of Zinc on Barrett's Metaplasia
- The Safety and Tolerability of Secretrol in Patients With Barrett's Esophagus
- Modulation of Esophageal Inflammation in Barrett's Esophagus by Omega-3 Fatty Acids
- A In-Vivo Esophageal Protocol for Detection of Neoplasia in the Digestive Tract
- Melatonin Associated to Acid Inhibition for Chemoprevention in Barret Esophagus: a Pilot Study
- Vitamin D Supplementation on 15-Prostaglandin Dehydrogenase Expression in Barrett's Esophagus
- Metformin Hydrochloride in Preventing Esophageal Cancer in Patients With Barrett Esophagus
- Esophageal Protocol for Detection of Neoplasia in the Digestive Tract
- Endoscopic Multispectral Imaging for the Early Detection of Barrett's Neoplasia
- A Feasibility Study of Confocal Microendoscopy in the Evaluation of Gastrointestinal Neoplasia -Project 1
- Evaluation of a Miniaturized Microscope Device for the Detection of Barrett's Neoplasia: A Pilot Study
- Trial of a Gastrin Receptor Antagonist in Barrett's Esophagus
- Efficacy and Safety of a Sunscreen Against Porfimer Sodium-induced Phototoxicity to Visible Light
- Study To Determine The Maximum Range of Light Doses At Two HPPH Doses With Acceptable Normal Tissue Toxicity For PDT Treatment Of High Grade Dysplasia,CIS or Early Adenocarcinoma In Barrett's Esophagus
- Study of Photodynamic Therapy (PDT) Using HPPH in Barrett's Esophagus
- Assessment of Zegerid on Esophageal pH in Patients With Barrett's Esophagus
- Ursodiol in Treating Patients With Barrett Esophagus and Low-Grade Dysplasia
- Does Intensive Acid Suppression Reduce Esophageal Inflammation and Recurrent Barrett's Esophagus Following Ablation?
- Clinical Studies on Bile Acids in Barrett's Esophagus
- Screening for Barrett's Esophagus in Otolaryngology Patients
- Barrett's Esophagus - 315 - 3 Way Cross Over
- Barrett's Esophagus - 315 - 3 Way Cross-Over
- The Effects of Sorafenib on Molecular Barrett's Esophagus Cancer
- Erlotinib in Treating Patients With Barrett Esophagus
- APE-Study: Ablation of Barrett's Mucosa vs. Surveillance Without Ablation in Patients Cured From Barrett's Cancer Combined With Randomization of Esomeprazole vs. Placebo for Symptomatic Reflux Control After Successful Barrett's Ablation
- Esomeprazole Magnesium With or Without Aspirin in Preventing Esophageal Cancer in Patients With Barrett Esophagus
- Efficacy and Safety of Sunitinib in Metastatic Gastric Cancer
- Pilot Study of Oral 852A for Elimination of High-Grade Dysplasia in Barrett's Esophagus
- A Phase III, Randomized, Study of Aspirin and Esomeprazole Chemoprevention in Barrett's Metaplasia
- An Open Label pH Comparison of Esomeprazole and Lansoprazole in Barrett's Esophagus Patients
- Defined Green Tea Catechin Extract in Preventing Esophageal Cancer in Patients With Barrett's Esophagus
- The Effect of Nexium on Transmucosal Esophageal Leak
- Celecoxib to Prevent Cancer in Patients With Barrett's Esophagus
- Eflornithine to Prevent Cancer in Patients With Barrett's Esophagus